Sign in

CIK 0001649094

  • Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464233385
Phone
+1 650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,185,988
in 8 filings, $4.8M under 10b5-1 plans

Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-18 GUGGENHIME ANDREW President and CFO Exercise or conversion +3,100 $5.35 $17K 43,725
2022-03-18 GUGGENHIME ANDREW President and CFO Sale −3,100 $26.13 $81K 40,625
2022-03-18 GUGGENHIME ANDREW President and CFO Exercise or conversion · Stock Option (right to buy) −3,100 509,118
2022-03-11 Fairman Jeff VP, Research Sale −10,000 $25.50 $255K 331,227
2022-03-10 Sauer Paul SVP Process Dev, Manufacturing Sale −6,000 $25.00 $150K 31,125
2022-03-02 Wassil Jim Chief Operating Officer Grant or award +25,000 42,944
2022-03-02 Wassil Jim Chief Operating Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2022-03-02 Wassil Jim Chief Operating Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2022-03-02 Fairman Jeff VP, Research Grant or award +6,000 16,629
2022-03-02 Fairman Jeff VP, Research Grant or award · Stock Option (right to buy) +33,000 33,000
2022-03-02 Dhaliwal Harpreet S. SVP Cml Mfg & Supply Chain Grant or award +17,500 17,500
2022-03-02 Dhaliwal Harpreet S. SVP Cml Mfg & Supply Chain Grant or award · Stock Option (right to buy) +45,000 45,000
2022-03-02 Sauer Paul SVP Process Dev, Manufacturing Grant or award +10,000 37,125
2022-03-02 Sauer Paul SVP Process Dev, Manufacturing Grant or award · Stock Option (right to buy) +60,000 60,000
2022-03-02 GUGGENHIME ANDREW President and CFO Grant or award +37,500 40,625
2022-03-02 GUGGENHIME ANDREW President and CFO Grant or award · Stock Option (right to buy) +225,000 225,000
2022-03-02 PICKERING GRANT Chief Executive Officer Grant or award +71,875 703,894
2022-03-02 PICKERING GRANT Chief Executive Officer Grant or award · Stock Option (right to buy) +431,250 431,250
2022-03-01 GUGGENHIME ANDREW President and CFO Exercise or conversion +6,200 $5.35 $33K 9,325
2022-03-01 GUGGENHIME ANDREW President and CFO Sale −6,200 $24.00 $149K 3,125

Page 50 of 51 · 1,004 trades